The Efficacy of Dual Time Point F-18 FDG PET Imaging for Grading of Brain Tumors

被引:27
|
作者
Kim, Dae-Weung [1 ]
Jung, Sang-Ah [1 ]
Kim, Chang-Guhn [1 ,2 ]
Park, Soon-Ah [1 ,2 ]
机构
[1] Wonkwang Univ, Sch Med, Dept Nucl Med, Iksan 570711, Jeollabuk Do, South Korea
[2] Wonkwang Univ, Sch Med, Inst Wonkwang Med Sci, Iksan 570711, Jeollabuk Do, South Korea
关键词
dual time point imaging; F-18 FDG PET/CT; brain tumor; grade of brain tumor; POSITRON-EMISSION-TOMOGRAPHY; FLUORODEOXYGLUCOSE; GLIOMAS; DIFFERENTIATION; CLASSIFICATION; SCAN;
D O I
10.1097/RLU.0b013e3181db4cfb
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Several studies have explored the usefulness of dual time point F-18 FDG positron emission tomography imaging (DTPI) in improving detection of brain metastases and tumors outside the brain, distinguishing malignant from benign. In the same manner, DTPI may show better performance to grade of brain tumors. Methods: Twenty-two lesions of 18 consecutive patients with primary or metastatic brain tumor were included prospectively. DTPI was performed and analyzed using maximum standardized uptake values (SUVmax), mean standardized uptake values within isocontour at 70% of maximum pixel values (SUViso), and retention index ( RI) for each lesion. Results: SUVmax and SUViso of the delayed image were more efficient than those of early images to classify lesions by the grade of tumors. The RI of SUVmax and SUViso were not significant to classify lesions. Conclusion: DTPI may be a better imaging method to grade the brain tumor than early imaging only.
引用
收藏
页码:400 / 403
页数:4
相关论文
共 50 条
  • [21] Dual time point 18F-FDOPA PET as a tool for characterizing brain tumors
    Gonzalez-Forero, M.
    Prieto, E.
    Dominguez, I.
    Vigil, C.
    Penuelas, I.
    Arbizu, J.
    REVISTA ESPANOLA DE MEDICINA NUCLEAR, 2011, 30 (02): : 88 - 93
  • [22] Brown fat uptake of 18F-FDG on dual time point PET/CT imaging
    Rashmizal, Hairil A. R.
    Noraini, A. R.
    Rossetti, C.
    Jalil, Abdul N.
    SINGAPORE MEDICAL JOURNAL, 2010, 51 (02) : E37 - E39
  • [23] Assessment of dual-time-point 18F-FDG-PET imaging for pulmonary lesions
    Laffon, Eric
    de Clermont, Henri
    Begueret, Hugues
    Vernejoux, Jean-Marc
    Thumerel, Matthieu
    Marthan, Roger
    Ducassou, Dominique
    NUCLEAR MEDICINE COMMUNICATIONS, 2009, 30 (06) : 455 - 461
  • [24] F-18 FDG PET imaging of muscle activity of runners
    Tashiro, M
    Fujimoto, T
    Kubota, K
    Fujiwara, T
    Miyake, M
    Watanuki, S
    Horikawa, E
    Sasaki, H
    Ido, T
    Itoh, M
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 195P - 195P
  • [25] Benign F-18 FDG uptake along a mediastinoscopy tract - Demonstration by F-18 FDG PET/CT imaging
    Roarke, Michael C.
    CLINICAL NUCLEAR MEDICINE, 2008, 33 (09) : 649 - 650
  • [26] F-18 FDG PET imaging of fibrolamellar hepatocellular carcinoma
    von Falck, Christian
    Rodt, Thomas
    Shin, Hoen-oh
    Knapp, Wolfram H.
    Galanski, Michael
    CLINICAL NUCLEAR MEDICINE, 2008, 33 (09) : 633 - 634
  • [27] NORMAL BRAIN F-18 FDG PET AND MRI ANATOMY
    SCHIFTER, T
    TURKINGTON, TG
    BERLANGIERI, SU
    HOFFMAN, JM
    MACFALL, JR
    PELIZZARI, CA
    TIEN, RD
    COLEMAN, RE
    CLINICAL NUCLEAR MEDICINE, 1993, 18 (07) : 578 - 582
  • [28] Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions
    Michihiro Nakayama
    Atsutaka Okizaki
    Shunta Ishitoya
    Miki Sakaguchi
    Junichi Sato
    Tamio Aburano
    Annals of Nuclear Medicine, 2013, 27 : 163 - 169
  • [29] Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions
    Nakayama, Michihiro
    Okizaki, Atsutaka
    Ishitoya, Shunta
    Sakaguchi, Miki
    Sato, Junichi
    Aburano, Tamio
    ANNALS OF NUCLEAR MEDICINE, 2013, 27 (02) : 163 - 169
  • [30] Superiority of F-18 FDG PET imaging for detection of a pheochromocytoma
    Sood, R
    Story, A
    Rossleigh, MA
    Haindl, W
    Guille, J
    Pillai, D
    CLINICAL NUCLEAR MEDICINE, 2006, 31 (01) : 13 - 15